Performances of a novel chemiluninescence ABEI-based NT-proBNP immunoassay.
(2022) Acta Cardiologica : an international journal of cardiology — Vol. 77, n° 2, p. 176-179 (2022)
Files
2022_Adamantidou_Acta_Cardiol.pdf
Open Access - Adobe PDF
- 890.06 KB
Details
- Authors
- Abstract
- Natriuretic peptides are widely used in clinical practice as cardiac markers for early diagnosis, prognosis and for the monitoring of treatment efficiency of heart Failure (HF). According to the clinical relevance of natriuretic peptides testing, it is important to assess the performances of novel platform for testing. Our study showed the overall good performances of a new NT-proBNP ABEI-based automated immunoassay.
- Affiliations
Citations
Adamantidou, C., Ahn, S., Rousseau, M., & Gruson, D. (2022). Performances of a novel chemiluninescence ABEI-based NT-proBNP immunoassay. Acta Cardiologica : an international journal of cardiology, 77(2), 176-179. https://doi.org/10.1080/00015385.2021.1903195 (Original work published 2022)